Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines
Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and…
Browsing Tag
DROIA Ventures
2 posts
Actio Biosciences Secures $55 Million in Series A Financing to Advance Precision Medicine Therapeutics
Actio Biosciences, a biotech firm focusing on genetics and precision medicine, has successfully raised $55 million in a…